HCA Healthcare, Inc. $HCA Shares Sold by Magellan Asset Management Ltd

Magellan Asset Management Ltd lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 100.0% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 179 shares of the company’s stock after selling 405,421 shares during the quarter. Magellan Asset Management Ltd’s holdings in HCA Healthcare were worth $76,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HCA. Brighton Jones LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth about $1,021,000. NewEdge Advisors LLC increased its position in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the period. Sivia Capital Partners LLC boosted its holdings in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the period. Focus Partners Advisor Solutions LLC increased its holdings in shares of HCA Healthcare by 8.2% in the 2nd quarter. Focus Partners Advisor Solutions LLC now owns 1,525 shares of the company’s stock valued at $584,000 after acquiring an additional 116 shares during the period. Finally, Wealthfront Advisers LLC grew its position in HCA Healthcare by 22.9% during the 2nd quarter. Wealthfront Advisers LLC now owns 21,444 shares of the company’s stock worth $8,215,000 after purchasing an additional 4,002 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on HCA shares. Leerink Partners increased their target price on shares of HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft increased their price objective on HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Robert W. Baird upped their price target on HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Royal Bank Of Canada boosted their price objective on shares of HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Wednesday, January 28th. Finally, Wall Street Zen downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $532.45.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president owned 30,003 shares of the company’s stock, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president owned 11,993 shares of the company’s stock, valued at $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 15,214 shares of company stock worth $7,797,595. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $526.39 on Wednesday. The company’s fifty day moving average is $490.31 and its two-hundred day moving average is $457.88. The firm has a market capitalization of $117.71 billion, a P/E ratio of 18.55, a PEG ratio of 1.64 and a beta of 1.36. HCA Healthcare, Inc. has a one year low of $295.00 and a one year high of $552.90.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter in the previous year, the firm earned $6.22 earnings per share. The firm’s revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.15%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.